HLA-B*27 DETECTION-Individual Target Drug-Products-Guangzhou SaiWang Biological technology co., LTD

PRODUCT

Address: Huangpu district Science town, Guangzhou, Kaiyuan Dadao no.188, G building, room 405-406

Phone: 020-87658152

Fax: 020-87658152-803

Home > Products > Individual Target Drug > Article

HLA-B*27 DETECTION

HLA-B*27 Detection

DETAILS

Relating to Disease: Ankylosing Spondylitis

RT-PCR & SYBR Green based detection method: each sample requires only 2 PCR rxns for detecting of HLA-B*27 and Internal Control. Analysis is based on Ct values.

Product Features

Required only hours from blood sample to results.
Designed for easy operation & analysis.
High sensitivity of major HLA-B*27 subtypes which include HLA-B*2701 ~ 2707.
Product Sheets available in right hand column.
Mix & Match design.

The presence of HLA-B*27 allele is strongly associated with ankylosing spondylitis (AS), a chronic inflammatory disease of the axial musculoskeletal system and a few other rheumatic disorders (Reiter's syndrome, acute anterior uveitis, and inflammatory bowel disease). HLA-B*27 testing is routinely used to screen for AS since ~90% of patients with AS have the HLA-B*27 allele. The geographical distribution of the different subtypes of HLA-B*27, with HLA-B*2705 being common in Caucasians and American Indians, HLA-B*2704 and 2706 in Asians and HLA-B*2702 in Mediterranean populations.

Previous：No

Next：HLA-B*5801 DETECTION